We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Further measures to be introduced to ensure patients who are prescribed montelukast for the treatment of asthma are informed of the risk of neuropsychiatric reactions
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
Clinicians are provided with actions to complete when managing infectious diseases in the asylum seeker population.
How to spot lumpy skin disease, what to do if you suspect it and how to prevent it spreading.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Signs that may suggest rabies in bats, what to do if you spot them and measures to prevent exposing yourself to the disease.
The T32 exemption allows you to treat non-hazardous pesticide washings in a biobed or biofilter.
Find out about coronavirus (COVID-19) treatments available outside of hospital, including information on free prescriptions and lateral flow tests.
If you use, produce or supply wood packaging material (WPM) to move goods to or from the EU or the rest of the world, you must make sure it meets international standards.
Get help to classify herbal medicines, vitamins, food preparations, supplements and tonics for import and export.
The MHRA will introduce a patient alert card to increase awareness among men taking finasteride about potential psychiatric and sexual side effects
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
There are different regulations which apply to devices and equipment including hand gels and PPE (personal protective equipment)
What to expect if you're sent to prison - prison rules and regulations, healthcare and education, prisoner rights
Healthcare professionals prescribing montelukast should be alert to the risk of neuropsychiatric reactions in all patients including children and adolescents. Reported neuropsychiatric reactions include sleep disorders, hallucinations, anxiety and depression, as well as changes in behaviour and mood. Healthcare professionals...
Read about talking therapies and counselling for mental health problems.
How to spot contagious equine metritis, what to do if you suspect it and measures to prevent its spread.
Information and service documents on the national DBS testing service offered by PHE to improve uptake of 12 month testing of infants born to hepatitis B infected mothers.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.